Brief: Fulgent Genetics Confirms Ability To Detect Omicron Variant With Rt-Pcr Tests For Covid-19
01/12/2021 22:02
Dec 1 (Reuters) - Fulgent Genetics Inc FLGT.O :
* FULGENT GENETICS CONFIRMS ABILITY TO DETECT OMICRON
VARIANT WITH
RT-PCR TESTS FOR COVID-19
* FULGENT GENETICS INC - CONFIDENT THAT ITS NEXT GENERATION
SEQUENCING (NGS) TESTS FOR COVID-19 CAN ACCURATELY IDENTIFY
VARIANT
Source text for Eikon: ID:nBwbdfQ8ha
Further company coverage: FLGT.O
Recent news on Fulgent Genetics
See all newsU.S. RESEARCH ROUNDUP-Cloudflare, Replimune, Walmart
Fulgent Genetics Inc reports results for the quarter ended June 30 - Earnings Summary
Fulgent Genetics Q2 revenue rises 20% sequentially, sees billing system transition delay
Brief: Fulgent Genetics Q2 Revenue USD 85.389 Million
Fulgent Genetics Inc expected to post a loss of 46 cents a share - Earnings Preview